Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...
Using ultrasound to guide Spinraza injection in SMA adults reduced the number of needle redirections, a study found.
China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal ...
A high-dose Spinraza treatment regimen was shown in a trial to safely improve motor function in untreated babies with spinal ...
A groundbreaking clinical trial testing QH104, an allogeneic B7H3-targeting CAR-γδT cell therapy, has shown promising results ...
The neuraxial delivery of drugs has become a cornerstone in the management of pain, leveraging the pivotal roles of the dorsal root ganglion (DRG) and dorsal horn. These spinal structures are key in ...
Epidural and spinal blocks are types of anesthesia commonly used during labor for childbirth. While spinal blocks offer total ...
A runny nose often results from common ailments but can sometimes indicate a cerebrospinal fluid (CSF) leak, which poses ...
During a Case-Based Roundtable® event, Tara K. Gregory, MD, discussed how to implement use of bispecific T-cell engagers in ...
Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...
Tominersen is an antisense oligonucleotide commercialized by Roche, with a leading Phase III program in Huntington Disease.